1. Pharmacokinetics of Selinexor: The First-in-Class Selective Inhibitor of Nuclear Export

   • Justin C. Bader
   • Albiruni R. Abdul Razak
   • Hongmei Xu

   Review Article 29 April 2021 Pages: 957 - 969

   

2. Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability

   • Shirley M. Tsunoda
   • Christopher Gonzales
   • Joseph D. Ma

   Review Article Open access 07 May 2021 Pages: 971 - 984

   

3. Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic Review

   • Erin Chung
   • Jonathan Sen
   • Winnie Seto

   Systematic Review 18 May 2021 Pages: 985 - 1001

   

4. Pharmacokinetic and Pharmacodynamic Profiles of Ethinylestradiol/Norgestimate Combination or Norethindrone upon Coadministration with Elagolix 150 mg Once Daily in Healthy Premenopausal Women

   • Robert A. Feldman
   • Yi-Lin Chiu
   • Juki Ng

   Original Research Article Open access 22 March 2021 Pages: 1003 - 1013

   

5. Effect of Kidney or Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Somapacitan: Two Open-Label, Parallel-Group Trials

   • Birgitte Bentz Damholt
   • Sarah Louise Dombernowsky
   • Michael Højby Rasmussen

   Original Research Article Open access 23 March 2021 Pages: 1015 - 1027

   

6. Pharmacokinetics and Exposure-Response Relationship of Teprotumumab, an Insulin-Like Growth Factor-1 Receptor-Blocking Antibody, in Thyroid Eye Disease

   • Yan Xin
   • Fengyan Xu
   • Srini Ramanathan

   Original Research Article Open access 26 March 2021 Pages: 1029 - 1040

   

7. Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil

   • Ashit Trivedi
   • Rajneet K. Oberoi
   • Edward Lee

   Original Research Article Open access 26 March 2021 Pages: 1041 - 1048

   

8. Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide

   • Shweta Urva
   • Tonya Quinlan
   • Corina Loghin

   Original Research Article Open access 29 March 2021 Pages: 1049 - 1059

   

9. Plasma Concentration and Pharmacodynamics of Edoxaban in Patients with Nonvalvular Atrial Fibrillation and Acute Heart Failure

   • Takeru Nabeta
   • Keisuke Kida
   • Takayuki Inomata

   Original Research Article Open access 30 March 2021 Pages: 1061 - 1071

   

10. Comment on: “Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation”

    • Satish Suhas
    • Vijay Kumar
    • Bangalore N. Gangadhar

    Letter to the Editor 26 April 2021 Pages: 1073 - 1075

11. Authors’ Reply to Suhas et al.: Comment on: “Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation”

    • Georgios Schoretsanitis
    • Maxim Kuzin
    • Ekkehard Haen

    Letter to the Editor 26 April 2021 Pages: 1077 - 1079